Original document(53 pages)  中文版
    The present invention relates to new D3 and D2 dopamine receptor subtype preferring ligands of formula (I): wherein R1 and R2 represent independently a substituent selected from hydrogen, alkyl, aryl, cycloalkyl, aroyl, or R1 and R2 may form a heterocyclic ring with the adjacent nitrogen atom; X represents an oxygen or sulphur atom; n is an integer of from 1 to 2, and/or geometric isomers and/or stereoisomers and/or diastereomers and/or salts and/or hydrates and/or solvates thereof, to the processes for producing the same, to pharmaceutical compositions containing the same and to their use in therapy and/or prevention of a condition which requires modulation of dopamine receptors.
Application Number
申请号
200480021950 Application Date
申请日
2004.05.21
Title 名称 (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
Publication Number
公开号
1829703 Publication Date
公开日
2006.09.06
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D243/08,C07D295/12,C07D295/14,C07D401/12,A61K31/495,A61P25/00
Applicant(s) Name
申请人
Richter Gedeon Vegyeszet
Address 地址
Inventor(s) Name 发明人 Againe Csongor Eva, Galambos Janos, Nogradi Katalin, Vago Istvan, Gyertyan Istvan, Kiss Bela, Laszlovszky Istvan, Laszy Judit
Attorney & Agent 代理人 tang xiaofeng

  
Benzo [1,2,5] thiadiazole compounds as CCK2 modulators
Process for producing an alkylene carbonate
1,4-benzodioxane sulfonic acid compound and use thereof as electron-acceptor material
Cyano anthranilamide insecticides
Piperidine compounds and pharmaceutical compositions containing them
Bicyclic imidazol derivatives against flaviviridae
Process for preparing intermediates useful to prepare certain antibacterial N-formyl hydroxylamines
Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
Nicotinamide derivatives useful as PDE4 inhibitors
3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.